Although CPEB4 is linked with abnormal post-transcriptional reprogramming in diseases such as cancer, liver disease, obesity, and neurodegenerative disorders [33–37], there is currently no evidence that CPEB4 serves any function in muscle. Here, CPEB4 is linked to obesity disorder.